Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-19
2006-09-19
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S484000
Reexamination Certificate
active
07109230
ABSTRACT:
Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.
REFERENCES:
patent: 5856353 (1999-01-01), Tung et al.
patent: 5990155 (1999-11-01), Tung et al.
patent: 6060476 (2000-05-01), Vazquez et al.
patent: 6172082 (2001-01-01), Vazquez et al.
patent: 6248775 (2001-06-01), Vazquez et al.
patent: 6319946 (2001-11-01), Hale et al.
patent: 6335460 (2002-01-01), Vazquez et al.
patent: 6392046 (2002-05-01), Tung et al.
patent: 6417387 (2002-07-01), Vazguez et al.
patent: 6455581 (2002-09-01), Vazquez et al.
patent: 6500832 (2002-12-01), Vazquez et al.
patent: 6534493 (2003-03-01), Vazquez et al.
patent: 2002/0049201 (2002-04-01), Hale et al.
patent: 2002/0052399 (2002-05-01), Vazquez et al.
patent: 2003/0069222 (2003-04-01), Tung et al.
patent: WO 99/67417 (1999-12-01), None
patent: WO 02/081478 (2002-10-01), None
patent: WO 02/083657 (2002-10-01), None
patent: WO 02/092595 (2002-11-01), None
Eissenstat Michael
Erickson John W.
Gulnik Sergei
Silva Abelardo
Heller Ehrman LLP
Saeed Kamal A.
Sequoia Pharmaceuticals, Inc.
LandOfFree
Resistance-repellent retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Resistance-repellent retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Resistance-repellent retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3533390